Neogenomics Inc
NASDAQ:NEO

  • LAST PRICE
    15.0405
  • TODAY'S CHANGE (%)
    0.9005 (6.3685%)
  • Bid / Lots
    15.0300/ 5
  • Ask / Lots
    15.0500/ 3
  • Open / Previous Close
    13.5500 / 14.1400
  • Day Range
    13.3500
    15.0800
  • 52 Week Range
    12.7700
    21.2200
  • Volume
    1,166,593

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Healthcare Facilities Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
NEO
Neogenomics Inc
1.8B
-24.1x
---
NHC
National Healthcare Corp
1.8B
20.4x
+1.85%
LTC
LTC Properties Inc
1.7B
16.4x
-11.14%
WGS
GeneDx Holdings Corp
2.1B
-23.7x
---
GRAH
Griffin-American Healthcare Reit III Inc
2.0B
-68.6x
---
USPH
US Physical Therapy Inc
1.2B
78.3x
-0.50%
As of 2024-11-05

Company Information

NeoGenomics, Inc. provides a range of oncology diagnostic testing and consultative services which includes technical laboratory services. The Company offers professional interpretation of laboratory test results by licensed physicians who specialize in pathology and oncology. Its segments include Clinical Services and Advanced Diagnostics. The Clinical Services segment consists of clinical cancer testing; interpretation and consultative services; molecular and NGS testing, and comprehensive technical and professional services offering. Its Clinical Services customers include community-based pathology and oncology practices, hospital pathology labs, reference labs, and academic centers. The Advanced Diagnostics segment consist of clinical trials and research, validation laboratory services, and informatics. Its Advanced Diagnostics customers include pharmaceutical companies to whom it provides testing and other services to support their research studies and clinical trials.

Contact Information

Headquarters
9490 Neogenomics WayFORT MYERS, FL, United States 33912
Phone
239-768-0600
Fax
775-329-0852

Executives

Independent Chairman of the Board
Lynn Tetrault
Chief Executive Officer, Director
Christopher Smith
Chief Financial Officer
Jeffrey Sherman
President - Advanced Diagnostics
Vishal Sikri
Chief Operating Officer, President - Informatics
Melody Harris

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.8B
Revenue (TTM)
$628.2M
Shares Outstanding
128.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.17
EPS
$-0.62
Book Value
$7.39
P/E Ratio
-24.1x
Price/Sales (TTM)
2.9
Price/Cash Flow (TTM)
---
Operating Margin
-15.17%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.